Castrate Sensitive Prostate Cancer clinical trials

Explore recruiting castrate sensitive prostate cancer clinical trials.

Recruiting castrate sensitive prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Castrate Sensitive Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2 trial of BMS-986365 in mCSPC patients with suboptimal PSA-response after 7 months of Androgen Deprivation Therapy (ADT) plus Androgen Receptor Pathway Inhibition (ARPI).

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Castrate Sensitive Prostate Cancer trials by city

Castrate Sensitive Prostate Cancer in Toronto Castrate Sensitive Prostate Cancer in Vancouver Castrate Sensitive Prostate Cancer in Montreal Castrate Sensitive Prostate Cancer in Calgary Castrate Sensitive Prostate Cancer in Edmonton Castrate Sensitive Prostate Cancer in Ottawa Castrate Sensitive Prostate Cancer in Winnipeg Castrate Sensitive Prostate Cancer in Quebec City Castrate Sensitive Prostate Cancer in Hamilton Castrate Sensitive Prostate Cancer in Kitchener Castrate Sensitive Prostate Cancer in London Castrate Sensitive Prostate Cancer in Halifax Castrate Sensitive Prostate Cancer in New York Castrate Sensitive Prostate Cancer in Los Angeles Castrate Sensitive Prostate Cancer in Chicago Castrate Sensitive Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease